Capreomycin sulfate how supplied: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Capreomycin sulfate}} {{CMG}} ; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CAPASTAT SULFATE (CAPREOMYCIN) INJ..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{chetan}} | {{CMG}} ; {{AE}} {{chetan}} | ||
==HOW SUPPLIED== | |||
Capastat® Sulfate, Capreomycin for Injection, USP, is available in: | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CAPASTAT SULFATE (CAPREOMYCIN) INJECTION, POWDER, FOR SOLUTION [AKORN] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=808e4421-2b9c-41e1-a82c-39256b112ae8 | publisher = | date = | accessdate }}</ref> | Vials: 1 g*, 10 mL size (No. 718) (1s) | ||
___________ | |||
*Equivalent to capreomycin activity. | |||
Store at controlled room temperature 15° to 30°C (59° to 86°F) prior to reconstitution. <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CAPASTAT SULFATE (CAPREOMYCIN) INJECTION, POWDER, FOR SOLUTION [AKORN] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=808e4421-2b9c-41e1-a82c-39256b112ae8 | publisher = | date = | accessdate }}</ref> | |||
==References== | ==References== | ||
Revision as of 00:23, 25 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
HOW SUPPLIED
Capastat® Sulfate, Capreomycin for Injection, USP, is available in:
Vials: 1 g*, 10 mL size (No. 718) (1s) ___________
- Equivalent to capreomycin activity.
Store at controlled room temperature 15° to 30°C (59° to 86°F) prior to reconstitution. [1]
References
- ↑ "CAPASTAT SULFATE (CAPREOMYCIN) INJECTION, POWDER, FOR SOLUTION [AKORN]". Text " accessdate " ignored (help)
Adapted from the FDA Package Insert.